Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3920 | TeleCAM Wiki | 1.00 |
| drug4692 | rDirectCAM Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D009103 | Multiple Sclerosis NIH | 0.24 |
| D012598 | Scoliosi NIH | 0.23 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The purpose of this study is to compare the effects of two delivery models of an evidence-based complementary alternative medicine (CAM) program that combines neurorehabilitative (functional) exercise, yoga, and Pilates for adults age 18-70 with multiple sclerosis (MS). CAM will be delivered as a 12-week program through two different delivery forms: On-site at a clinic (DirectCAM) and telerehabilitation (TeleCAM). Participants will be randomly assigned to one of these two groups. **On March 16th, 2020, the University of Alabama at Birmingham halted all onsite non-essential research in response to the Covid-19 pandemic. Since then, the study has begun to conduct all testing remotely through videoconferencing technology. In addition, another study group, remote DirectCAM (rDirectCAM), has been incorporated into the study to continue the 12-week program delivery for newly recruited participants via videoconferencing technology.**
Description: Measured by 36-Item Short Form Survey (SF-36).
Measure: Pain Time: 48 weeksDescription: Measured by Modified Fatigue Impact Scale (MFIS).
Measure: Fatigue Time: 48 weeksDescription: Measured by 36-Item Short Form Survey (SF-36).
Measure: Quality of life Time: 48 weeksDescription: Measured by the Godin Leisure Time Exercise Questionnaire (GLTEQ).
Measure: Physical activity Time: 48 weeksDescription: Measured using the Berg Balance Scale (BBS).
Measure: Balance Time: 48 weeksDescription: Measured using the 6-minute Walk Test (6MWT).
Measure: Endurance Time: 48 weeksDescription: Measured using the Timed 25-Foot Walk (T25-FW).
Measure: Gait Time: 48 weeksDescription: Measured using a hand-held dynamometer.
Measure: Strength Time: 48 weeksDescription: Measured by the Multidimensional Outcome Expectations for Exercise Scale (MOEES).
Measure: Outcome expectations for exercise Time: 48 weeksDescription: Measured by the Exercise Self-efficacy Scale.
Measure: Exercise self-efficacy Time: 48 weeksDescription: Measured by the Social Provisions Scale.
Measure: Social support for exercise Time: 48 weeksDescription: Measured by the Exercise Goal-setting Scale.
Measure: Exercise self-regulation Time: 48 weeksAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports